Emily Anne Ferenczi, B.M., B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalomalacia | 1 | 2018 | 15 | 0.690 |
Why?
|
| Delusions | 1 | 2020 | 298 | 0.650 |
Why?
|
| Frontotemporal Dementia | 1 | 2020 | 209 | 0.650 |
Why?
|
| Face | 1 | 2022 | 977 | 0.570 |
Why?
|
| Lighting | 1 | 2016 | 220 | 0.490 |
Why?
|
| Ion Pumps | 1 | 2012 | 14 | 0.470 |
Why?
|
| Corpus Striatum | 1 | 2016 | 1238 | 0.360 |
Why?
|
| Reward | 1 | 2016 | 847 | 0.360 |
Why?
|
| Neurons | 6 | 2018 | 9375 | 0.360 |
Why?
|
| Neural Inhibition | 1 | 2012 | 590 | 0.340 |
Why?
|
| Receptors, GABA-A | 1 | 2012 | 626 | 0.320 |
Why?
|
| Ammonia | 1 | 2008 | 238 | 0.320 |
Why?
|
| Prefrontal Cortex | 3 | 2016 | 2046 | 0.310 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 503 | 0.300 |
Why?
|
| Motivation | 1 | 2016 | 1901 | 0.290 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1191 | 0.280 |
Why?
|
| Psychotic Disorders | 1 | 2020 | 2847 | 0.280 |
Why?
|
| Coma | 1 | 2008 | 381 | 0.270 |
Why?
|
| Neural Pathways | 5 | 2016 | 3020 | 0.260 |
Why?
|
| Glioblastoma | 1 | 2018 | 3346 | 0.230 |
Why?
|
| Fluid Therapy | 1 | 2007 | 608 | 0.230 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2008 | 1627 | 0.220 |
Why?
|
| Light | 4 | 2016 | 1433 | 0.220 |
Why?
|
| Facies | 1 | 2022 | 193 | 0.210 |
Why?
|
| Hippocampus | 2 | 2015 | 3628 | 0.200 |
Why?
|
| Opsins | 3 | 2018 | 18 | 0.190 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 567 | 0.190 |
Why?
|
| West Nile Fever | 2 | 2011 | 92 | 0.180 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 1755 | 0.180 |
Why?
|
| Models, Neurological | 4 | 2016 | 1781 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 969 | 0.170 |
Why?
|
| Brain | 5 | 2017 | 25208 | 0.160 |
Why?
|
| Membrane Potentials | 2 | 2016 | 1167 | 0.160 |
Why?
|
| Saimiri | 1 | 2018 | 336 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 2137 | 0.160 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8805 | 0.150 |
Why?
|
| Rats, Inbred LEC | 1 | 2016 | 3 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 3015 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3149 | 0.140 |
Why?
|
| Implants, Experimental | 1 | 2015 | 104 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1879 | 0.130 |
Why?
|
| Nerve Net | 2 | 2018 | 2139 | 0.130 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 40 | 0.130 |
Why?
|
| Wireless Technology | 1 | 2015 | 102 | 0.130 |
Why?
|
| Extracellular Space | 1 | 2016 | 606 | 0.120 |
Why?
|
| Mesencephalon | 1 | 2016 | 321 | 0.120 |
Why?
|
| Brain Chemistry | 1 | 2017 | 1015 | 0.120 |
Why?
|
| Diet | 1 | 2010 | 7565 | 0.110 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2012 | 61 | 0.110 |
Why?
|
| Neocortex | 1 | 2015 | 386 | 0.110 |
Why?
|
| Xenopus laevis | 1 | 2016 | 1010 | 0.110 |
Why?
|
| Horse Diseases | 1 | 2011 | 52 | 0.100 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 162 | 0.100 |
Why?
|
| Dopamine | 2 | 2016 | 1593 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2597 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9549 | 0.100 |
Why?
|
| West Nile virus | 1 | 2011 | 83 | 0.100 |
Why?
|
| Protons | 1 | 2016 | 1065 | 0.100 |
Why?
|
| Oocytes | 1 | 2016 | 1217 | 0.100 |
Why?
|
| tau Proteins | 1 | 2020 | 1649 | 0.100 |
Why?
|
| Fear | 2 | 2015 | 1368 | 0.100 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 1739 | 0.100 |
Why?
|
| Axons | 2 | 2018 | 1732 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2018 | 1056 | 0.090 |
Why?
|
| Corpus Callosum | 1 | 2014 | 728 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 495 | 0.090 |
Why?
|
| Animals | 15 | 2018 | 169404 | 0.090 |
Why?
|
| Fast Foods | 1 | 2010 | 173 | 0.080 |
Why?
|
| Amygdala | 1 | 2015 | 1260 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 227 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 11403 | 0.080 |
Why?
|
| Myocardial Reperfusion | 1 | 2008 | 350 | 0.080 |
Why?
|
| Heart Failure, Systolic | 1 | 2008 | 127 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2015 | 1808 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8542 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4266 | 0.070 |
Why?
|
| Myotonic Dystrophy | 1 | 2006 | 77 | 0.070 |
Why?
|
| Lipids | 1 | 2017 | 3242 | 0.070 |
Why?
|
| Memory | 1 | 2015 | 2143 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 22663 | 0.070 |
Why?
|
| Professional Practice | 1 | 2007 | 333 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 14438 | 0.070 |
Why?
|
| Humans | 17 | 2022 | 715818 | 0.070 |
Why?
|
| Rana temporaria | 1 | 2003 | 4 | 0.060 |
Why?
|
| Hypertonic Solutions | 1 | 2003 | 94 | 0.060 |
Why?
|
| Oxygen | 1 | 2016 | 4162 | 0.060 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2003 | 103 | 0.060 |
Why?
|
| Rats | 3 | 2016 | 24852 | 0.060 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2009 | 790 | 0.060 |
Why?
|
| Hand Strength | 1 | 2006 | 452 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3317 | 0.060 |
Why?
|
| Video Recording | 1 | 2008 | 944 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1418 | 0.060 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2003 | 129 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 696 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2010 | 1161 | 0.060 |
Why?
|
| Calcium | 1 | 2016 | 5800 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2016 | 3804 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2292 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2010 | 2048 | 0.050 |
Why?
|
| Proteins | 1 | 2017 | 6070 | 0.050 |
Why?
|
| Male | 12 | 2018 | 350352 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 658 | 0.050 |
Why?
|
| Medical Records | 1 | 2007 | 1423 | 0.050 |
Why?
|
| Anxiety | 1 | 2015 | 3916 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 797 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2003 | 494 | 0.050 |
Why?
|
| Kinetics | 2 | 2011 | 6654 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 1315 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 1867 | 0.050 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 1405 | 0.050 |
Why?
|
| Hungary | 2 | 2011 | 80 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2016 | 6539 | 0.050 |
Why?
|
| Female | 11 | 2020 | 377229 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 34430 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2008 | 1345 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2008 | 9004 | 0.040 |
Why?
|
| Risk Factors | 3 | 2018 | 70879 | 0.040 |
Why?
|
| Life Style | 1 | 2010 | 3730 | 0.040 |
Why?
|
| Mice | 5 | 2017 | 80373 | 0.040 |
Why?
|
| Sodium | 1 | 2003 | 1599 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2008 | 2650 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5694 | 0.040 |
Why?
|
| Risk | 1 | 2010 | 9799 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 2033 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6730 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2016 | 6701 | 0.040 |
Why?
|
| Middle Aged | 5 | 2020 | 214666 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11655 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 40887 | 0.040 |
Why?
|
| Learning | 2 | 2015 | 1603 | 0.040 |
Why?
|
| Stents | 1 | 2008 | 3212 | 0.040 |
Why?
|
| Body Weight | 1 | 2007 | 4687 | 0.040 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2015 | 42 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 2017 | 256 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 11201 | 0.030 |
Why?
|
| Electromagnetic Phenomena | 1 | 2016 | 153 | 0.030 |
Why?
|
| Miniaturization | 1 | 2015 | 151 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2010 | 9596 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 11953 | 0.030 |
Why?
|
| Depression | 1 | 2012 | 7268 | 0.030 |
Why?
|
| Halorhodopsins | 1 | 2012 | 8 | 0.030 |
Why?
|
| Dependovirus | 1 | 2018 | 733 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2012 | 32 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 13219 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 2015 | 354 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3897 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2008 | 58326 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2008 | 8544 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 403 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9849 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 2015 | 465 | 0.030 |
Why?
|
| Nociceptors | 1 | 2015 | 441 | 0.030 |
Why?
|
| Thalamus | 1 | 2018 | 1012 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 2012 | 144 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 333 | 0.030 |
Why?
|
| Microinjections | 1 | 2012 | 367 | 0.030 |
Why?
|
| Biophysics | 1 | 2012 | 392 | 0.030 |
Why?
|
| Horses | 1 | 2011 | 294 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2012 | 324 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 2012 | 358 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 2014 | 533 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7095 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 475 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 2011 | 354 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 1070 | 0.020 |
Why?
|
| Temperature | 1 | 2015 | 2143 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 2015 | 4164 | 0.020 |
Why?
|
| AIDS Serodiagnosis | 1 | 2009 | 183 | 0.020 |
Why?
|
| Hypertension | 1 | 2008 | 8270 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2015 | 1439 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 480 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 1977 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2015 | 961 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2010 | 62040 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3587 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2012 | 1759 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2008 | 23476 | 0.020 |
Why?
|
| Heart Failure | 1 | 2010 | 10041 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3687 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 39305 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2840 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2012 | 1030 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 1528 | 0.020 |
Why?
|
| Action Potentials | 1 | 2011 | 1780 | 0.020 |
Why?
|
| HIV Infections | 1 | 2009 | 15784 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2006 | 406 | 0.020 |
Why?
|
| Phylogeny | 1 | 2011 | 2792 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2006 | 611 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 2676 | 0.010 |
Why?
|
| Health Resources | 1 | 2008 | 926 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2011 | 2995 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 1996 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 5050 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4561 | 0.010 |
Why?
|
| Aged | 2 | 2007 | 162468 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5266 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16311 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2008 | 3164 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9034 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14902 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2008 | 4630 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10666 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 20733 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15911 | 0.010 |
Why?
|
| Adult | 2 | 2009 | 212279 | 0.000 |
Why?
|